The Cancer Genome Atlas (TCGA), the NIH research program that has helped set the standards for characterizing the genomic underpinnings of dozens of cancers on a large scale, is moving to its next phase.
Monday, May 11 - Tuesday, May 12, 2015 National Institutes of Health, Bethesda, Md. This open scientific meeting will consist of collaborative workshops, poster sessions, and plenary sessions.
The Cancer Genome Atlas researchers are mapping the genetic changes in 20 cancers. Find out which cancers have been selected for study, the criteria for selection and the scientific questions being asked about each cancer.
Explore how The Cancer Genome Atlas works, the components of the TCGA Research Network and TCGA's place in the cancer genomics field in the Program Overview.
Steps Towards Precision Medicine: Utilizing FFPE Specimens for Comprehensive Genomic Characterization
Roy W. Tarnuzzer, Ph.D., the Biospecimen Core Resource Program Manager at the TCGA Program Office, provides an overview of the Formalin-fixed Paraffin Pilot Project, an initiative to investigate best practices for use of FFPE specimens in genomic studies.